GSK1904529A
GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity[1][2].
Product Specifications
CAS Number
1089283-49-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; IGF-1R; Insulin Receptor
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/GSK1904529A.html
Purity
99.03
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=C(N3C=CC=CC3=N2)C4=NC(NC5=CC(CC)=C(C=C5OC)N6CCC(CC6)N7CCN(CC7)S(=O)(C)=O)=NC=C4)=CC=C1OC)NC8=C(C=CC=C8F)F
Molecular Formula
C44H47F2N9O5S
Molecular Weight
851.96
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![LACTB2 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1A8]](https://cdn.genprice.uk/products/937/6868c334994c49e6dc3f1b83/imageurl/ta502585bm.webp)
LACTB2 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1A8]
